Talk:Cost Plus Drugs

This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Companies Low‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany

Low This article has been rated as Low-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Low	This article has been rated as Low-importance on the project's importance scale.

Requesting Additional Secondary Sources

Latest comment: 4 years ago1 comment1 person in discussion

I just marked this with template:primary. Prior UE didn't leave a note when adding the advert template, so discuss here.

There's not much here so far, but the sources given are definitely too close to the subject and most of the published details seem to originate from the Inc. interview with Cuban. Unfortunately I'm not having much luck finding good material. I'll leave a note on DRosenbach's talk as well. — Preceding unsigned comment added by 70.179.12.188 (talk) 05:29, 16 June 2022 (UTC)Reply

Name Change back to "Mark Cuban Cost Plus Drug Company"

Latest comment: 3 years ago2 comments2 people in discussion

The company's name was never changed to "Cost Plus Drugs", only the internet domain name is listed as "CostPlusDrugs.com". Domains are usually listed as a shorter or abbreviated alternative due to search purposes. The actual company name, which is more relevant for this page would be its actual DBA which is "Mark Cuban Cost Plus Drug Company". This is listed on the company's main webpage. DropAnchor9907 (talk) 00:29, 25 January 2023 (UTC)Reply

If you want the page moved then open a WP:Requested move and discuss it properly. Don't just make a single comment and then move it. By the way [https://costplusdrugs.com/ uses "Cost Plus Drugs". CambridgeBayWeather, Uqaqtuq (talk), Huliva 08:13, 26 January 2023 (UTC)Reply

Improvement to business model section and growth milestones

Latest comment: 2 months ago1 comment1 person in discussion

While this article does a great job highlighting the pricing model for the company, its' origins, and the evolution of the number of drugs the organizaiton offers to its' customers, there is still room for opportunity to discuss the business model in its' form as a 503b organization, how the manufacturing facility is now officially completed, or the creation of the Team Cuban Card and its partnerships with various pharmacies. I intend to add more of this content to improve the validity of the article and keep it current. BurntOrangeMD (talk) 22:23, 3 June 2026 (UTC)Reply